Insights

Expanding Clinical Adoption FibriCheck is currently implemented by over 2000 clinical practices across 43 countries, indicating a strong foothold in the medical community and potential for further expansion into new healthcare markets and institutional partnerships.

Recognition & Awards The company's recent awards for best mobile health app and eHealth innovation highlight its credibility and technological leadership, making it appealing for collaborations with healthcare providers and insurers seeking validated digital health solutions.

Technology Integration FibriCheck's solutions are device-agnostic and integrated with wearable technology like Samsung Galaxy watches, opening opportunities to target wearable device manufacturers and health tech distributors interested in cardiac health monitoring.

Regulatory Validity With CE, FDA, and MHRA approvals, FibriCheck's software meets high safety and efficacy standards, enabling sales targeting hospitals, clinics, and healthcare systems that prioritize certified digital health tools for cardiac care.

Growth in Data & Research The recent launch of FibriCheck Data Registry signifies a focus on high-quality real-world data collection, presenting opportunities to collaborate with research institutions or offer data-driven solutions to healthcare providers seeking evidence-based insights.

FibriCheck Tech Stack

FibriCheck uses 8 technology products and services including Microsoft Advertising, Cloudflare CDN, Cloudflare, and more. Explore FibriCheck's tech stack below.

  • Microsoft Advertising
    Advertising
  • Cloudflare CDN
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Supersized
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Google Maps
    Maps
  • Bootstrap
    UI Frameworks
  • Ruby on Rails
    Web Frameworks

Media & News

FibriCheck's Email Address Formats

FibriCheck uses at least 1 format(s):
FibriCheck Email FormatsExamplePercentage
First.Last@fibricheck.comJohn.Doe@fibricheck.com
88%
Last_First@fibricheck.comDoe_John@fibricheck.com
5%
First.MiddleLast@fibricheck.comJohn.MichaelDoe@fibricheck.com
5%
First@fibricheck.comJohn@fibricheck.com
2%

Frequently Asked Questions

What is FibriCheck's official website and social media links?

Minus sign iconPlus sign icon
FibriCheck's official website is fibricheck.com and has social profiles on LinkedInCrunchbase.

What is FibriCheck's NAICS code?

Minus sign iconPlus sign icon
FibriCheck's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does FibriCheck have currently?

Minus sign iconPlus sign icon
As of December 2025, FibriCheck has approximately 27 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Ceo & Co-Founder: L. G.Chief Technology Officer: C. H.Vp Partnerships / Integration: S. T.. Explore FibriCheck's employee directory with LeadIQ.

What industry does FibriCheck belong to?

Minus sign iconPlus sign icon
FibriCheck operates in the Medical Equipment Manufacturing industry.

What technology does FibriCheck use?

Minus sign iconPlus sign icon
FibriCheck's tech stack includes Microsoft AdvertisingCloudflare CDNCloudflareSupersizedjQueryGoogle MapsBootstrapRuby on Rails.

What is FibriCheck's email format?

Minus sign iconPlus sign icon
FibriCheck's email format typically follows the pattern of First.Last@fibricheck.com. Find more FibriCheck email formats with LeadIQ.

When was FibriCheck founded?

Minus sign iconPlus sign icon
FibriCheck was founded in 2014.

FibriCheck

Medical Equipment ManufacturingFlanders, Belgium11-50 Employees

FibriCheck is an innovative digital health company dedicated to transforming the way cardiac care is delivered. We do so by providing a medically certified, software-only and device-agnostic solution that redefines the way cardiac arrhythmias are detected and managed.

We empower people to take control of their heart health by offering them our PPG-technology in a user-friendly setting. Users can measure their heart rhythm in 60 seconds, using the camera of their smartphone without any additional hardware. These measurements provide valuable insights into the heart rhythm which help people attain peace of mind and help to improve the outcomes of cardiac arrhythmias by speeding up the process of getting the right diagnosis and treatment. 

FibriCheck can be used throughout the entire patient lifecycle, from early detection and secondary prevention to the management of cardiac arrhythmias, such as atrial fibrillation (AF). On top of that, our software can also be used for symptom management such as palpitations, as symptoms can be logged with each measurement. These symptoms are combined with the results of the measurements in reports, which can easily be shared with physicians for further follow-up. 

Accuracy and safety are of the highest importance to us, which is why we make continuous efforts towards regulatory compliance and clinical validation. We are a CE class IIa medical device with regulatory approvals of the MHRA, FDA and TGA. 

FibriCheck is currently implemented by over 2000 clinical practices, and is the trusted partner in heart health for over 1 million users in 43 countries. Various integration possibilities are available.

πŸ“š Want to learn about PPG-technology from our experts? bit.ly/3XmqU7r
πŸ§‘πŸ« Curious about our clinical studies? bit.ly/3XkghCj
🀝 Interested in collaborating with FibriCheck? bit.ly/43h0UwQ
πŸ’‘ Want to receive the latest news and product updates? bit.ly/3MF0ybM
🫢 We're always looking for ambitious people: bit.ly/30cT6gw

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $1M

    FibriCheck's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    FibriCheck's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Β© LeadIQ, Inc. All rights reserved.